Cann Group (ASX:CAN) share price rockets on NAB (ASX:NAB) update

The Cann Group Ltd (ASX:CAN) share price is rocketing higher on Monday after National Australia Bank (ASX:NAB) provided a $50 million debt facility…

| More on:
ASX Cannabis share price represented by asx investor holding card with cannabis leaf on it

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Cann Group Ltd (ASX: CAN) share price has started the week in sensational form.

In afternoon trade the cannabis company's shares are up a sizeable 13% to 35 cents.

Why is the Cann Group share price rocketing higher?

Investors have been buying the company's shares on Monday after it provided an update on its debt facility.

According to the release, the company has received credit approval from National Australia Bank (ASX: NAB) for a $50 million secured debt facility. Management expects to complete the execution of documentation with the banking giant within the next month.

Why does Cann need a $50 million debt facility?

The release explains that the loan is a construction facility which will be used by Cann to complete the first stage of its state-of-the-art medicinal cannabis production site near Mildura.

Management advised that it is being provided through NAB's agribusiness division, which it feels represents a strong endorsement of its strategic growth plans.

It notes that the approval clears a path to recommence construction at the Mildura site, with work expected to be underway in February 2021.

The first stage of the Mildura site has an estimated 9 month build time, with first product expected to be processed and released by March 2022. This will come at a total cost of $112 million, with $53 million already spent on site works and the facility superstructure. The balance will be funded by the new bank loan facility and current cash reserves.

Once complete, the first stage of the project will provide annual capacity to produce 12,500 kgs of dry flower equivalent. 

Cann Group's CEO, Peter Crock, commented: "The commissioning of production at Mildura is an important step in Cann's plan to produce GMP certified medicinal cannabis at scale. The facility will utilise world-leading technology, providing Cann with a globally competitive unit price based on substantial economies of scale."

"Securing the support of a tier one bank is a strong validation of our strategic growth plans. Given the building demand for our products, we have the confidence to immediately ramp up production as soon as the facility is ready," he concluded.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Winning woman smiles and holds big cup while losing woman looks unhappy with small cup
Share Gainers

Here are the top 10 ASX 200 shares today

It was a dour Tuesday for ASX investors.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why Brightstar Resources, Immutep, Pilbara Minerals, and Race Oncology shares are roaring higher

These shares are having a strong session on Tuesday. But why?

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Healthcare Shares

Guess which ASX 300 healthcare share is rocketing 28% on global expansion news

Investors are piling into the ASX 300 healthcare share on Tuesday. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a Garfield kind of Monday for investors.

Read more »

Happy shareholders clap and smile as they listen to a company earnings report.
Share Gainers

Why Artrya, Clinuvel, Imugene, and Pilbara Minerals shares are storming higher today

These shares are starting the week in a positive fashion. But why?

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Share Gainers

4 ASX 200 stocks smashing the benchmark this week

Investors have been piling into these four ASX 200 stocks this week. Let’s see why.

Read more »